Keen Insight for Industry Trend: Newcastle Disease Vaccine Market Value Analysis by 2026

Newcastle disease is a viral disease caused by avian paramyxovirus type 1 (APMV-1). The roots of this virus can be traced back to the genus Avulavirus, belonging to the Paramyxoviridae family. Newcastle disease virus (NDV) is a contagious bird disease, which affects various domestic birds such as chicken and turkey, among other birds. Chicken is found to be more susceptible to this disease. The viral strain can be classified into various phenotypes depending upon the virulence expression in chicken. These include the least virulent strains, moderately virulent strains, which are also called mesogenic strains, and the most virulent strains also known as velogenic strains. The disease is transmitted by the fecal-oral route, owing to the exposure to the infected birds’ excretion, contaminated food, water, and equipment, among others. This disease is transmittable to humans.

Market trend Snapshot

Global Newcastle Disease Vaccine market was valued at 287 million USD in 2019 and expected to reach 359 million USD by 2026, growing at a CAGR of 3.24%. This report provides comprehensive and in-depth analysis and prediction of the Newcastle Disease Vaccine industry.

From Base year 2018 to forecast year 2026

Get FREE Sample of Newcastle Disease Vaccine Market Report at:

https://www.globalmarketmonitor.com/reports/191821-newcastle-disease-vaccine-market-report-2019.html#download-sample

Key Market Players Profile

Various market pacemakers covered in the report are Merial, QYH Biotech, DHN, HVRI, CEVA, Elanco, Yebio, Zoetis, FATRO, Kyoto Biken, CAVAC, Ringpu Biology, Vaksindo, ChengDu Tecbond, Sindh Poultry Vaccine Centre, and Merck Animal Health. The report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies, which will help companies create strategies to take advantages of the emerging opportunities in the future. Production and consumption are estimated to continue developing with a stable growth rate during the forecast period. As a result of meeting the surging demand, more manufacturers are expected to go into this industry.

North America holds the largest Newcastle Disease Vaccine market share

The report covers the major countries analysis in North America, Europe, Asia Pacific, and the rest of the world. Furthermore, policy mobilization, social dynamics, development trends, and economic development in these countries are also taken into consideration.

North America accounted for the largest market share of 32.67% owing to growing awareness among people and ongoing research & development. Europe was the second largest market with a share of 29.87%. The Asia Pacific is expected to witness robust growth during the forecast period. This growth can be attributed to the significant contribution from emerging economies such as China and India. High prevalence of Newcastle disease in the region and growing dependence on poultry as a source of protein drives the Newcastle disease vaccines market in the region.

Newcastle Disease Vaccine Type and Application Sketch

By type

  • Live Vaccines
  • Killed Vaccines

By application

  • Chicken
  • Duck & Goose
  • Other

Get FREE Sample of Newcastle Disease Vaccine Market Report at:

https://www.globalmarketmonitor.com/reports/191821-newcastle-disease-vaccine-market-report-2019.html#download-sample

Newcastle Disease Vaccine Report provides

  • Potential opportunities and challenges in Newcastle Disease Vaccine market
  • Current and future market outlook in the developed and emerging markets
  • Detailed analysis of the segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • Comprehensive & in-depth research and after-sales warranty by GlobalMarketMonitor

Table of Content

1 Report Overview

1.1  Product Definition and Scope

1.2  PEST (Political, Economic, Social and Technological) Analysis of Newcastle Disease Vaccine Market

2 Market Trends and Competitive Landscape

3 Segmentation of Newcastle Disease Vaccine Market by Types

4 Segmentation of Newcastle Disease Vaccine Market by End-Users

5 Market Analysis by Major Regions

6 Product Commodity of Newcastle Disease Vaccine Market in Major Countries

7 North America Newcastle Disease Vaccine Landscape Analysis

8 Europe Newcastle Disease Vaccine Landscape Analysis

9 Asia Pacific Newcastle Disease Vaccine Landscape Analysis

10 Latin America, Middle East & Africa Newcastle Disease Vaccine Landscape Analysis  

11 Major Players Profile

11.1 Merial

11.1.1 Merial Company Profile and Recent Development

11.1.2 Market Performance

11.1.3 Product and Service Introduction

11.2 QYH Biotech

11.3 DHN

11.4 HVRI

11.5 CEVA

11.6 Elanco

11.7 Yebio

11.8 Zoetis

11.9 FATRO

11.10 Kyoto Biken

11.11 CAVAC

11.12 Ringpu Biology

11.13 Vaksindo

11.14 ChengDu Tecbond

11.15 Sindh Poultry Vaccine Centre

11.16 Merck Animal Health

Target Audience:

  • Newcastle Disease Vaccine manufacturers
  • Distributors and resellers of Newcastle Disease Vaccine
  • Newcastle Disease Vaccine industry associations
  • Product managers, Newcastle Disease Vaccine industry administrator, C-level executives of the industries
  • Market Research and consulting firms

Get FREE Sample of Newcastle Disease Vaccine Market Report at:

https://www.globalmarketmonitor.com/reports/191821-newcastle-disease-vaccine-market-report-2019.html#download-sample

Contact

Global Market Monitor

One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,

NY 11201, USA

Name: Rebecca Hall

Phone: + 1 (347) 467 7721

Email: info@globalmarketmonitor.com

Web Site: https://www.globalmarketmonitor.com

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.